CGTX vs REGN: Which Stock is Better?

Side-by-side comparison of Cognition Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

CGTX

Cognition Therapeutics Inc

$1.11

REGN

Regeneron Pharmaceuticals Inc

$750.57

Key Metrics Comparison

MetricCGTXREGNWinner
Market Cap$97.40M$78.87BREGN
P/E RatioN/A17.98REGN
EPS (TTM)$N/A$41.48REGN
Revenue Growth0.0%0.0%REGN
Gross Margin0.0%44.6%REGN

Analyze CGTX

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CGTX or REGN a better investment?

Comparing CGTX and REGN: Cognition Therapeutics Inc has a market cap of $97.40M while Regeneron Pharmaceuticals Inc has $78.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CGTX and REGN?

CGTX (Cognition Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CGTX or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CGTX or REGN?

REGN has higher revenue growth at 0.0% vs 0.0% for CGTX.

Which company is more profitable: CGTX or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for CGTX.

Which is the larger company: CGTX or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.87B compared to $97.40M for CGTX.

Should I buy CGTX or REGN in 2026?

Both CGTX and REGN have investment merit. CGTX trades at $1.11 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CGTX and REGN stock?

Key differences: Market Cap ($97.40M vs $78.87B), P/E Ratio (N/A vs 18.0x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).

Popular Stock Comparisons